| [1] |
Quigley HA. Neuronal death in glaucoma[J]. Prog Retin Eye Res, 1999, 18(1): 39-57.
|
| [2] |
Weinreb RN, Leung CKS, Crowston JG, et al. Primary open-angle glaucoma[J]. Nat Rev Dis Primer, 2016, 2(1): 16067.
|
| [3] |
Tham YC, Li X, Wong TY, et al. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040[J]. Ophthalmology, 2014, 121(11): 2081-2090.
|
| [4] |
Zhang X, Olson DJ, Le P, et al. The Association Between Glaucoma, Anxiety, and Depression in a Large Population[J]. Am J Ophthalmol, 2017, 183: 37-41.
|
| [5] |
Agorastos A, Skevas C, Matthaei M, et al. Depression, Anxiety, and Disturbed Sleep in Glaucoma[J]. J Neuropsychiatry Clin Neurosci, 2013, 25(3): 205-213.
|
| [6] |
Wang SY, Singh K, Lin SC. Prevalence and Predictors of Depression Among Participants With Glaucoma in a Nationally Representative Population Sample[J]. Am J Ophthalmol, 2012, 154(3): 436-444.
|
| [7] |
Giacometti HHAR, Coelho LF, Iankilevich LG, et al. Prevalence of anxiety and depression among patients with glaucoma[J]. Front Psychol, 2024, 15: 1410890.
|
| [8] |
Lim NCS, Fan CHJ, Yong MKH, et al. Assessment of Depression, Anxiety, and Quality of Life in Singaporean Patients With Glaucoma[J]. J Glaucoma, 2016, 25(7): 605-612.
|
| [9] |
Abe RY, Silva LNP, Silva DM, et al. Prevalence of depressive and anxiety disorders in patients with glaucoma: a cross-sectional study[J]. Arq Bras Oftalmol, 2021, 84: 31-36.
|
| [10] |
Eramudugolla R, Wood J, Anstey KJ. Co-morbidity of depression and anxiety in common age-related eye diseases: a population-based study of 662 adults[OL]. Front Aging Neurosci, [2013-05-25].
URL
|
| [11] |
Jonas JB, Wei WB, Xu L, et al. Self-rated depression and eye diseases: The Beijing Eye Study[J]. PLOS ONE, 2018, 13(8): e0202132.
|
| [12] |
Ramesh PV, Morya AK, Azad A, et al. Navigating the intersection of psychiatry and ophthalmology: A comprehensive review of depression and anxiety management in glaucoma patients[J]. World J Psychiatry, 2024, 14(3): 362-369.
|
| [13] |
Chen YY, Lai YJ, Wang JP, et al. The association between glaucoma and risk of depression: a nationwide population-based cohort study[J]. BMC Ophthalmol, 2018, 18(1): 146.
|
| [14] |
Mabuchi F, Yoshimura K, Kashiwagi K, et al. High Prevalence of Anxiety and Depression in Patients With Primary Open-angle Glaucoma[J]. J Glaucoma, 2008, 17(7): 552.
|
| [15] |
Diniz-Filho A, Abe RY, Cho HJ, et al. Fast Visual Field Progression is Associated with Depressive Symptoms in Patients with Glaucoma[J]. Ophthalmology, 2016, 123(4): 754.
|
| [16] |
Skalicky S, Goldberg I. Depression and Quality of Life in Patients With Glaucoma: A Cross-sectional Analysis Using the Geriatric Depression Scale-15, Assessment of Function Related to Vision, and the Glaucoma Quality of Life-15[J]. J Glaucoma, 2008, 17(7): 546-551.
|
| [17] |
Zhang X, Liang Y, Huang Y, et al. Evaluation of the Observational Associations and Shared Genetics Between Glaucoma With Depression and Anxiety[J]. Investig Opthalmology Vis Sci, 2024, 65(3): 12.
|
| [18] |
Rezapour J, Nickels S, Schuster AK, et al. Prevalence of depression and anxiety among participants with glaucoma in a population-based cohort study: The Gutenberg Health Study[J]. BMC Ophthalmol, 2018, 18(1): 157.
|
| [19] |
Berchuck S, Jammal A, Mukherjee S, et al. Impact of anxiety and depression on progression to glaucoma among glaucoma suspects[J]. Br J Ophthalmol, 2021, 105(9): 1244-1249.
|
| [20] |
Shin DY, Jung KI, Park HYL, et al. The effect of anxiety and depression on progression of glaucoma[J]. Sci Rep, 2021, 11(1): 1769.
|
| [21] |
Jung Y, Han K, Wang S min, et al. Effect of depressive symptom and depressive disorder on glaucoma incidence in elderly[J]. Sci Rep, 2021, 11(1): 5888.
|
| [22] |
Kong X, Yan M, Sun X, et al. Anxiety and Depression are More Prevalent in Primary Angle Closure Glaucoma Than in Primary Open-Angle Glaucoma：[J]. J Glaucoma, 2015, 24(5): e57-e63.
|
| [23] |
Zhou C, Qian S, Wu P, et al. Anxiety and depression in Chinese patients with glaucoma: Sociodemographic, clinical, and self-reported correlates[J]. J Psychosom Res, 2013, 75(1): 75-82.
|
| [24] |
Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma[J]. Br J Ophthalmol, 2012, 96(6): 821-825.
|
| [25] |
Allison K, Patel DG, Greene L. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis[J]. JAMA Netw Open, 2021, 4(5): e218348-e218348.
|
| [26] |
Rudnicka AR, Mt-Isa S, Owen CG, et al. Variations in Primary Open-Angle Glaucoma Prevalence by Age, Gender, and Race: A Bayesian Meta-Analysis[J]. Investig Opthalmology Vis Sci, 2006, 47(10): 4254.
|
| [27] |
Hunt I M, Richards N, Bhui K, et al. Suicide rates by ethnic group among patients in contact with mental health services: an observational cohort study in England and Wales[J]. Lancet Psychiatry, 2021, 8(12): 1083-1093.
|
| [28] |
Ma SN, Liu XH, Cai WS. Preventive noninvasive vagal nerve stimulation reduces insufficient sleep-induced depression by improving the autonomic nervous system[J]. Biomed Pharmacother, 2024, 173: 116344.
|
| [29] |
Bajkó Z, Szekeres CC, Kovács KR, et al. Anxiety, depression and autonomic nervous system dysfunction in hypertension[J]. J Neurol Sci, 2012, 317(1-2): 112-116.
|
| [30] |
Won E, Kim YK. Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression[J]. Curr Neuropharmacol, 2016, 14(7): 665-673.
|
| [31] |
Marshall H, Berry EC, Torres SD, et al. Association Between Body Mass Index and Primary Open Angle Glaucoma in Three Cohorts[J]. Am J Ophthalmol, 2023, 245: 126-133.
|
| [32] |
Kim HA, Han K, Lee YA, et al. Differential Association of Metabolic Risk Factors with Open Angle Glaucoma according to Obesity in a Korean Population[J]. Sci Rep, 2016, 6(1): 38283.
|
| [33] |
Liu W, Ling J, Chen Y, et al. The Association between Adiposity and the Risk of Glaucoma: A Meta-Analysis[J]. J Ophthalmol, 2017: 1-12.
|
| [34] |
Fulton S, Décarie-Spain L, Fioramonti X, et al. The menace of obesity to depression and anxiety prevalence[J]. Trends Endocrinol Metab, 2022, 33(1): 18-35.
|
| [35] |
Milaneschi Y, Simmons WK, Van Rossum EFC, et al. Depression and obesity: evidence of shared biological mechanisms[J]. Mol Psychiatry, 2019, 24(1): 18-33.
|
| [36] |
Faith MS, Butryn M, Wadden TA, et al. Evidence for prospective associations among depression and obesity in population-based studies[J]. Obes Rev, 2011, 12(5): e438-e453.
|
| [37] |
Davy KP, Orr JS. Sympathetic nervous system behavior in human obesity[J]. Neurosci Biobehav Rev, 2009, 33(2): 116-124.
|
| [38] |
Russo B, Menduni M, Borboni P, et al. Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System[J]. Int J Mol Sci, 2021, 22(10): 5187.
|
| [39] |
Liu B, Zhao Y, Zhang H. The Effect of Autonomic Nervous System Dysfunction on the Progression of Primary Open-Angle Glaucoma[J]. Int J Gen Med, 2022, 15: 4565-4573.
|
| [40] |
Gherghel D, Hosking S, Orgul S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma[J]. Surv Ophthalmol, 2004, 49(5): 491-508.
|
| [41] |
Lee JY, Kim JM, Lee KY, et al. Relationships between Obesity, Nutrient Supply and Primary Open Angle Glaucoma in Koreans[J]. Nutrients, 2020, 12(3): 878.
|
| [42] |
Macri CZ, Wong CX, Tu SJ, et al. Association of obesity and metabolic syndrome with incident primary open angle glaucoma in the UK Biobank[J]. Clin Experiment Ophthalmol, 2025, 53(2): 133-139.
|
| [43] |
Gracitelli CPB, Duque-Chica GL, Roizenblatt M, et al. Intrinsically Photosensitive Retinal Ganglion Cell Activity Is Associated with Decreased Sleep Quality in Patients with Glaucoma[J]. Ophthalmology, 2015, 122(6): 1139-1148.
|
| [44] |
Steiger A, Pawlowski M. Depression and Sleep[J]. Int J Mol Sci, 2019, 20(3): 607.
|
| [45] |
Fang H, Tu S, Sheng J, et al. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment[J]. J Cell Mol Med, 2019, 23(4): 2324-2332.
|
| [46] |
Alvaro PK, Roberts RM, Harris JK. A Systematic Review Assessing Bidirectionality between Sleep Disturbances, Anxiety, and Depression[J]. Sleep, 2013, 36(7): 1059-1068.
|
| [47] |
Walsh JT, Montplaisir J. Familial glaucoma with sleep apnoea: a new syndrome？[J]. Thorax, 1982, 37(11): 845-849.
|
| [48] |
Mojon DS, Hess CW, Goldblum D, et al. High prevalence of glaucoma in patients with sleep apnea syndrome[J]. Ophthalmology, 1999, 106(5): 1009-1012.
|
| [49] |
McMonnies CW. Glaucoma history and risk factors[J]. J Optom, 2017, 10(2): 71-78.
|
| [50] |
Yuan Y, Wang W, Shang X, et al. Association between statin use and the risks of glaucoma in Australia: a 10-year cohort study[J]. Br J Ophthalmol, 2023, 107(1): 66-71.
|
| [51] |
Read JR, Sharpe L, Modini M, et al. Multimorbidity and depression: A systematic review and meta-analysis[J]. J Affect Disord, 2017, 221: 36-46.
|
| [52] |
Autry AE, Monteggia LM. Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders[J]. Pharmacol Rev, 2012, 64(2): 238-258.
|
| [53] |
Basavarajappa D, Galindo-Romero C, Gupta V, et al. Signalling pathways and cell death mechanisms in glaucoma: Insights into the molecular pathophysiology[J]. Mol Aspects Med, 2023, 94: 101216.
|
| [54] |
Dekeyster E, Geeraerts E, Buyens T, et al. Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB[J]. PLoS One, 2015, 10(11): e0142067.
|
| [55] |
Gupta V, You Y, Li J, et al. BDNF impairment is associated with age-related changes in the inner retina and exacerbates experimental glaucoma[J]. Biochim Biophys Acta BBA Mol Basis Dis, 2014, 1842(9): 1567-1578.
|
| [56] |
Pinazo-Durán MD, Zanón-Moreno V, García-Villanueva C, et al. Biochemical-molecular-genetic biomarkers in the tear film, aqueous humor, and blood of primary open-angle glaucoma patients[J]. Front Med, 2023, 10: 1157773.
|
| [57] |
Lambuk L, Mohd Lazaldin MA, Ahmad S, et al. Brain-Derived Neurotrophic Factor-Mediated Neuroprotection in Glaucoma: A Review of Current State of the Art[J]. Front Pharmacol, 2022, 13: 875662.
|
| [58] |
Quigley HA, McKinnon SJ, Zack DJ, et al. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats[J]. Invest Ophthalmol Vis Sci, 2000, 41(11): 3460-3466.
|
| [59] |
Weinreb RN, Aung T, Medeiros FA. The Pathophysiology and Treatment of Glaucoma: A Review[J]. JAMA, 2014, 311(18): 1901.
|
| [60] |
Ma YT, Hsieh T, Forbes ME, et al. BDNF Injected into the Superior Colliculus Reduces Developmental Retinal Ganglion Cell Death[J]. J Neurosci, 1998, 18(6): 2097-2107.
|
| [61] |
Drouyer E, Dkhissi-Benyahya O, Chiquet C, et al. Glaucoma Alters the Circadian Timing System[J]. PLoS One, 2008, 3(12): e3931.
|
| [62] |
Jean-Louis G, Zizi F, Lazzaro DR, et al. Circadian rhythm dysfunction in glaucoma: A hypothesis[J]. J Circadian Rhythms, 2008, 6: 1.
|
| [63] |
Ren C, Luan L, Wui-Man Lau B, et al. Direct Retino-Raphe Projection Alters Serotonergic Tone and Affective Behavior[J]. Neuropsychopharmacology, 2013, 38(7): 1163-1175.
|
| [64] |
Coppen AJ, Doogan D. Serotonin and its place in the pathogenesis of depression[J]. J Clin Psychiatry, 1988, 49(Suppl): 4-11.
|
| [65] |
Lynch G, Whitson JT, Brown H, et al. Topical BlockerTherapy and Central Nervous System Side Effects[J]. Arch Ophthalmol, 1988, 106(7): 908-911.
|
| [66] |
Cimolai N. A review of neuropsychiatric adverse events from topical ophthalmic brimonidine[J]. Hum Exp Toxicol, 2020, 39(10): 1279-1290.
|
| [67] |
Wilson MR, Coleman AL, Yu F, et al. Depression in patients with glaucoma as measured by self-report surveys[J]. Ophthalmology, 2002, 109(5): 1018-1022.
|
| [68] |
Janz NK, Wren PA, Guire KE, et al. Fear of Blindness in the Collaborative Initial Glaucoma Treatment Study[J]. Ophthalmology, 2007, 114(12): 2213-2220.
|
| [69] |
Patten SB, Williams JVA, Lavorato DH, et al. Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort[J]. Gen Hosp Psychiatry, 2008, 30(5): 407-413.
|
| [70] |
Nemeroff CB, Goldschmidt-Clermont PJ. Heartache and heartbreak-the link between depression and cardiovascular disease[J]. Nat Rev Cardiol, 2012, 9(9): 526-539.
|
| [71] |
Fiedorowicz JG. Depression and Cardiovascular Disease: An Update on How Course of Illness May Influence Risk[J]. Curr Psychiatry Rep, 2014, 16(10): 492.
|
| [72] |
Davidson K, Jonas BS, Dixon KE, et al. Do Depression Symptoms Predict Early Hypertension Incidence in Young Adults in the CARDIA Study？[J]. Arch Intern Med, 2000, 160(10): 1495.
|
| [73] |
Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study[J]. Arch Fam Med, 1997, 6(1): 43-49.
|
| [74] |
Meyer CM, Armenian HK, Eaton WW, et al. Incident hypertension associated with depression in the Baltimore Epidemiologic Catchment area follow-up study[J]. J Affect Disord, 2004, 83(2-3): 127-133.
|
| [75] |
Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms[J]. Lancet Diabetes Endocrinol, 2015, 3(6): 461-471.
|
| [76] |
Eaton WW, Armenian H, Gallo J, et al. Depression and Risk for Onset of Type II Diabetes: A prospective population-based study[J]. Diabetes Care, 1996, 19(10): 1097-1102.
|
| [77] |
Tabák AG, Akbaraly TN, Batty GD, et al. Depression and type 2 diabetes: a causal association？[J]. Lancet Diabetes Endocrinol, 2014, 2(3): 236-245.
|
| [78] |
Breslau N, Lipton RB, Stewart WF, et al. Comorbidity of migraine and depression: Investigating potential etiology and prognosis[J]. Neurology, 2003, 60(8): 1308-1312.
|
| [79] |
Hoehn-Saric R, McLeod DR, Funderburk F, et al. Somatic Symptoms and Physiologic Responses in Generalized Anxiety Disorderand Panic Disorder: An Ambulatory Monitor Study[J]. Arch Gen Psychiatry, 2004, 61(9): 913-921.
|
| [80] |
Martin E I, Ressler KJ, Binder E, et al. The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology[J]. Psychiatr Clin North Am, 2009, 32(3): 549-575.
|
| [81] |
Shin DY, Jeon SJ, Park HYL, et al. Posterior scleral deformation and autonomic dysfunction in normal tension glaucoma[J]. Sci Rep, 2020, 10(1): 8203.
|
| [82] |
Park HYL, Jung SH, Park SH, et al. Detecting autonomic dysfunction in patients with glaucoma using dynamic pupillometry[J]. Medicine (Baltimore), 2019, 98(11): e14658.
|
| [83] |
Pasquale LR. Vascular and autonomic dysregulation in primary open-angle glaucoma：[J]. Curr Opin Ophthalmol, 2016, 27(2): 94-101.
|
| [84] |
Grieshaber MC, Flammer J. Blood flow in glaucoma[J]. Curr Opin Ophthalmol, 2005, 16(2): 79-83.
|
| [85] |
Park HYL, Park SH, Park CK. Central Visual Field Progression in Normal-Tension Glaucoma Patients With Autonomic Dysfunction[J]. Investig Opthalmology Vis Sci, 2014, 55(4): 2557.
|
| [86] |
Richa S, Yazbek JC. Ocular Adverse Effects of Common Psychotropic Agents: A Review[J]. CNS Drugs, 2010, 24(6): 501-526.
|
| [87] |
Chen VCH, Ng MH, Chiu WC, et al. Effects of selective serotonin reuptake inhibitors on glaucoma: A nationwide population-based study[J]. PLOS ONE, 2017, 12(3): e0173005.
|
| [88] |
Sundbom L, Bingefors K. The influence of symptoms of anxiety and depression on medication nonadherence and its causes: a population based survey of prescription drug users in Sweden[J]. Patient Prefer Adherence, 2013: 805.
|
| [89] |
Wolfram C, Stahlberg E, Pfeiffer N. Patient-Reported Nonadherence with Glaucoma Therapy[J]. J Ocul Pharmacol Ther, 2019, 35(4): 223-228.
|